Choice of Estimated Glomerular Filtration Rate Equation Impacts Drug-Dosing Recommendations and Risk Stratification in Patients With Chronic Kidney Disease Undergoing Percutaneous Coronary Interventions
Author:
Funder
Eli Lilly
AstraZeneca
The Medicines Company
Bristol-Myers Squibb
Sanofi
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference25 articles.
1. Characteristics and in-hospital outcomes of patients with non-ST-segment elevation myocardial infarction and chronic kidney disease undergoing percutaneous coronary intervention;Hanna;J Am Coll Cardiol Intv,2011
2. Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry;Tsai;J Am Coll Cardiol Intv,2014
3. Outcome of contemporary percutaneous coronary intervention in the elderly and the very elderly: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium;Thomas;Clin Cardiol,2011
4. Prediction of creatinine clearance from serum creatinine;Cockcroft;Nephron,1976
5. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation;Levey;Ann Intern Med,1999
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Estimation of kidney function for medication dosing in adult patients with chronic kidney disease: a practice update;Journal of Pharmacy Practice and Research;2023-11-13
2. Impact of New eGFR Equations on Risk Assessment In Patients Undergoing Transcatheter Aortic Valve Implantation;Cardiovascular Revascularization Medicine;2023-04
3. Key Considerations regarding the Renal Risks of Iodinated Contrast Media: The Nephrologist’s Role;Cardiorenal Medicine;2023
4. Trends and outcomes of percutaneous coronary intervention during the COVID-19 pandemic in Michigan;PLOS ONE;2022-09-26
5. One-Year Ischemic and Bleeding Events According to Renal Function in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Treated With Percutaneous Coronary Intervention and Third-Generation Antiplatelet Drugs;The American Journal of Cardiology;2022-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3